HK Stock MarketDetailed Quotes
01061 ESSEX BIO-TECH
- 2.530
- -0.060-2.32%
Trading Jun 4 10:31 CST
1.44BMarket Cap5.22P/E (TTM)
2.530High2.530Low20.00KVolume2.530Open2.590Pre Close50.60KTurnover0.00%Turnover Ratio5.22P/E (Static)567.54MShares3.55052wk High0.75P/B1.44BFloat Cap1.91552wk Low0.09Dividend TTM567.54MShs Float9.127Historical High0.090Dividend LFY0.00%Amplitude-0.597Historical Low2.530Avg Price1000Lot Size3.56%Div YieldTTM3.56%Div Yield LFY
About ESSEX BIO-TECH Company
Yisheng Biotechnology Co., Ltd. (“Yisheng Biotech Group and Company”) was incorporated in the Cayman Islands on July 31, 2000, and listed on the Hong Kong Stock Exchange on June 27, 2001. The Group's main business is the manufacture and sale of biopharmaceuticals for the treatment of body surface trauma and eye damage. In addition, it is also engaged in the development of bFGF drugs and other eye medicine projects for new indications. The group has now successfully developed a series of genetically engineered biopharmaceuticals. Three of these products have been classified as national-level Class I new drugs. The main brands are Beifuji, Beifuxu, and Beifuxin.
Company Profile
Symbol01061
Company NameESSEX BIO-TECH
ISINKYG312371035
Listing DateJun 23, 2011
Registered AddressCayman Islands
Chairmanmingchi yan
Secretaryliwen qiu
Audit InstitutionHong Kong Lixin Dehao Certified Public Accountants Limited
Company CategoryOther
Registered OfficeCricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands
Head Office and Principal Place of BusinessRoom 3206, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong
Fiscal Year Ends12-31
Employees1481
MarketHong Kong motherboard
Phone(+852) 2587 7838
Fax(+852) 2587 7363
Emailessex@essexbio.com
Websitehttp://www.essexbio.com
Business Yisheng Biotechnology Co., Ltd. is an investment holding company mainly engaged in the production and sale of biopharmaceuticals to treat surface trauma and eye damage. The company develops biopharmaceuticals based on recombinant DNA technology. The company's main brands are Beifuji, Beifushu, and Beifuxin. The company operates through two business segments. The Pharmaceutical Division is engaged in the manufacture and sale of pharmaceuticals. The Marketing Services segment is engaged in the business of distributing and promoting third-party pharmaceutical products.
Company Executives
- Name
- Position
- Salary
- mingchi yan
- presidencies，Executive Director，Remuneration Committee Members，Nomination Committee Members
- --
- haizhou fang
- Executive Director，Managing Director，Authorized Representative
- --
- xianlong yan
- Executive Director，Deputy Managing Director of the Company
- --
- liwen qiu
- Executive Director，Qualified accountants，Authorized Representative，Company Secretary
- --
- zhiying feng
- Independent Non-Executive Director，Chairman of the Audit Committee，Nomination Committee Members，Remuneration Committee Members
- --
- wenxing zhen
- Independent Non-Executive Director，Remuneration Committee Members，Nomination Committee Members，Audit Committee Members
- 128.33K
- meimei qiu
- Independent Non-Executive Director，Chairman of the Nomination Committee，Remuneration Committee Chairman，Audit Committee Members
- --
- qi xue
- Chief Scientist
- --
- zanshun zheng
- Director of Zhuhai Yisheng Biotechnology Co., Ltd.，Managing Director of Zhuhai Yisheng Biopharmaceutical Co., Ltd.，Managing Director of Zhuhai Yisheng Pharmaceutical Co., Ltd.
- --
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg